Legal Representation
Attorney
Ruth E. Freeburg
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 16, 2013 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 16, 2013 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 14, 2013 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 12, 2013 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2013 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 12, 2013 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 14, 2012 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 19, 2012 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 19, 2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 30, 2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 11, 2012 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 9, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 23, 2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 2, 2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 30, 2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 30, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 27, 2011 | RFTP | Z | REMOVED FROM TEAS PLUS | Loading... |
| Oct 27, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 27, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 27, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 21, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 11, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 8, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical services, namely, providing a database in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; and namely, providing evidence-based treatment protocols by comparing standard treatment therapies with clinical outcomes regarding disease conditions, namely, cardiovascular disease
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CARDIAC CARE"